Synthesis and structural analysis of a new class of azaspiro[3.3]heptanes as building blocks for medicinal chemistry

Organic Letters

Volumn 12, Issue 9, 2010, Pages 1944-1947

  Burkhard, Johannes A ^a   Guérot, Carine ^a,b   Knust, Henner ^b   Rogers Evans, Mark ^b   Carreira, Erick M ^a  

^a ETH ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPTANE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; HEPTANES; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 77951860659     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol1003302     Document Type: Article

References (42)

1. Wuitschik, G.; Rogers-Evans, M.; Müller, K.; Fischer, H.; Wagner, B.; Schuler, F.; Polonchuk, L.; Carreira, E. M. Angew. Chem., Int. Ed. 2006, 45, 7736-7739
2. Wuitschik, G.; Rogers-Evans, M.; Buckl, A.; Bernasconi, M.; Märki, M.; Godel, T.; Fischer, H.; Wagner, B.; Parrilla, I.; Schuler, F.; Schneider, J.; Alker, A.; Schweizer, W. B.; Müller, K.; Carreira, E. M. Angew. Chem., Int. Ed. 2008, 47, 4512-4515
3. Wuitschik, G.; Carreira, E. M.; Rogers-Evans, M.; Müller, K. Oxetan-3-one: chemistry and synthesis. In Process Chemistry in the Pharmaceutical Industry; Gadamasetti, K.; Braish, T., Eds.; CRC Press: Boca Raton, 2008; pp 217-229.
4. Details can be found in: Wuitschik, G. Oxetanes in Drug Discovery. Ph.D. Thesis, ETH Zurich, Zurich, 2008.
5. Wuitschik, G.; Carreira, E. M.; Wagner, B.; Fischer, H.; Parrilla, I.; Schuler, F.; Rogers-Evans, M.; Muller, K. J. Med. Chem. 2010, 53, in press.
6. Burkhard, J. A.; Wuitschik, G.; Rogers-Evans, M.; Müller, K.; Carreira, E. M. Angew. Chem., Int. Ed. 2010, 49, in press.
7. Burkhard, J. A.; Wagner, B.; Fischer, H.; Schuler, F.; Müller, K.; Carreira, E. M. Angew. Chem., Int. Ed. 2010, 49, in press
8. For other recent work of oxetanes in the field of drug discovery, see: Duncton, M. A. J.; Estiarte, M. A.; Tan, D.; Kaub, C.; OMahony, D. J. R.; Johnson, R. J.; Cox, M.; Edwards, W. T.; Wan, M.; Kincaid, J.; Kelly, M. G. Org. Lett. 2008, 10, 3259-3262
9. Duncton, M. A. J.; Estiarte, M. A.; Johnson, R. J.; Cox, M.; OMahony, D. J. R.; Edwards, W. T.; Kelly, M. G. J. Org. Chem. 2009, 74, 6354-6357
10. Patents: for hexahydropyrimidines, consider
11. Kodumuru, V. WO 2007/046867, 2007.
12. Faucher, N. E.; Martres, P.; Meunier, S. WO 2009/047240, 2009. Hemiaminals
13. Aquino, C. J.; Chong, P. Y.; Duan, M.; Kazmierski, W. M. WO 2004/055011, 2004.
14. Guillemont, J. E. G.; Pasquier, E. T. J. WO 2005/070924, 2005.
15. Ballhause, H.; Engelhardt, G.; Landgraf, C. A.; Mayer, N.; Roth, W.; Schumacher, K.; Prox, A. EP 413302, 1990.
16. Schriewer, M.; Grohe, K.; Krebs, A.; Pedersen, U.; Schenke, T.; Haller, I.; Metzger, K. G.; Endermann, R.; Zeiler, H.-J. EP 391132, 1989. Thioaminals: Bateson, J. H.; Gilpin, M. L. WO 1998/039311, 1998.
17. The N -piperonyl-substituted system was prepared in order to facilitate the various analyses.
18. For an overview of the chemistry of these ketones, see
19. Dejaegher, Y.; Kuzmenok, N. M.; Zvonok, A. M.; De Kimpe, N. Chem. Rev. 2002, 102, 29-60
20. Granvogl, M.; Christlbauer, M.; Schieberle, P. J. Agric. Food Chem. 2004, 52, 2797-2802
21. Trost, B. M.; Schinski, W. L.; Chen, F.; Mantz, I. B. J. Am. Chem. Soc. 1971, 93, 676-684
22. Robinson, P. L.; Kelly, J. W.; Evans, S. A. Phosphorus Sulfur 1987, 31, 59-70
23. Robinson, P. L.; Barry, C. N.; Kelly, J. W.; Evans, S. A. J. Am. Chem. Soc. 1985, 107, 5210-5219
24. For compound 9, see ref 1. Cyclobutane 10 is known; see, e.g.: Afzal, M.; Walton, J. C. J. Chem. Soc., Perkin Trans. 2 1999, 93, 937-945
25. Katritzky, A. R.; Cundy, D. J.; Chen, J. J. Heterocycl. Chem. 1994, 34, 271-275
26. Axenrod, T.; Watnick, C.; Yazdekhasti, H. J. Org. Chem. 1995, 60, 1959-1964
27. Singh, A.; Sikder, N.; Sikder, A. K. Indian J. Chem. 2005, 44B, 2560-2563
28. Mayer, R.; Funk, K. F. Angew. Chem. 1961, 73, 578-579
29. Kozikowski, A. P.; Fauq, A. H. Synlett 1991, 783-784
30. Maheshwari, K. K.; Berchtold, G. A. J. Chem. Soc. D, Chem. Commun. 1969, 13
31. Hutton, C. A.; Jaber, R.; Otaegui, M.; Turner, J. J.; Turner, P.; White, J. M.; Bacskay, G. B. J. Chem. Soc., Perkin Trans. 2 2002, 1066-1071
32. Okuma, K.; Tanaka, Y.; Kaji, S.; Ohta, H. J. Org. Chem. 1983, 48, 5133-5134
33. For an enantioselective synthesis of oxetanes, see: Sone, T.; Lu, G.; Matsunaga, S.; Shibasaki, M. Angew. Chem., Int. Ed. 2009, 48, 1677-1680
34. Although the preparation of 16 was not reported, it was suggested as a bifunctional scaffold: Stocks, M. J.; Wilden, G. R. H.; Pairaudeau, G.; Perry, M. W. D.; Steele, J.; Stonehouse, J. P. Chemmedchem 2009, 4, 800-808
35. Burkhard, J.; Carreira, E. M. Org. Lett. 2008, 10, 3525-3526
36. See, for example
37. Otani, Y.; Nagae, O.; Naruse, Y.; Inagaki, S.; Ohno, M.; Yamaguchi, K.; Yamamoto, G.; Uchiyama, M.; Ohwada, T. J. Am. Chem. Soc. 2003, 125, 15191-15199
38. For a general discussion about nonplanar amides, consider: Winkler, F. K.; Dunitz, J. D. J. Mol. Biol. 1971, 59, 169-182
39. Ohwada, T.; Okamoto, I.; Shudo, K.; Yamaguchi, K. Tetrahedron Lett. 1998, 39, 7877-7880
40. See ref 18: N -tosylaziridine (i, = 291.2°, α = 120.5°), N -tosylazetidine (i, = 338.8°, α = 142.75°).
41. A search of the recent patent literature produces a sizable listing. A selection of these include: China: US 2009163512; Novartis: WO 2009077367, WO 2009068682; Boehringer Ingelheim: WO 2009070485; Schering: WO 2009061699, WO 2009058856, WO 2009055331; Syngenta: US 2009068140; Sanofi Aventis: EP 2007, -291010; Santhera: WO 2009010299; Vertex: WO 2009006315; Merck: WO 2008156726.
42. Oxetan-3-one is now commercially available from multiple sources, e.g. Synthonix, Inc. (see advertisement in Chem. Eng. News 2009, 87 (42)).